EpiPen Maker Finalizes Settlement
Last week, Mylan, the maker of EpiPen, finalized a $465 million government agreement settling allegations the company had overcharged Medicaid for its emergency allergy injectors for a decade.
According to ABC News, charges against the company were brought after rival Sanofi filed a whistleblower lawsuit under the False Claims Act and tipped off the Department of Justice. This is the second settlement Mylan has made with the government since 2009 for alleged overbilling.
Some have criticized the latest settlement, because the dollar amount is less than Medicaid was overcharged by the company. Mylan has been in the middle of much controversy surrounding life-saving EpiPens, for raising the price of the life-saving device from $94 in 2007 to $608 in 2016. Experts estimate it costs less than $10 to manufacture an EpiPen.